4//SEC Filing
Deck Kelly 4
Accession 0001739614-24-000009
CIK 0001739614other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:41 PM ET
Size
10.0 KB
Accession
0001739614-24-000009
Insider Transaction Report
Form 4
Inhibrx, Inc.INBX
Deck Kelly
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2024-03-05$35.72/sh−10,417$372,095→ 9,583 totalExercise: $34.16Exp: 2032-01-11→ Common Stock (10,417 underlying) - Exercise/Conversion
Stock Option (right to buy)
2024-03-04$35.40/sh−53,958$1,910,113→ 16,042 totalExercise: $33.63Exp: 2031-01-15→ Common Stock (53,958 underlying) - Exercise/Conversion
Stock Option (right to buy)
2024-03-04$35.60/sh−8,125$289,250→ 21,875 totalExercise: $23.30Exp: 2033-01-03→ Common Stock (8,125 underlying)
Footnotes (3)
- [F1]Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on January 3, 2024, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
- [F2]Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on January 15, 2022, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
- [F3]Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on January 11, 2023, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
Documents
Issuer
Inhibrx, Inc.
CIK 0001739614
Entity typeother
Related Parties
1- filerCIK 0001819427
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 4:41 PM ET
- Size
- 10.0 KB